Difference between revisions of "Fecal calprotectin"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal | last1 = Ayling | first1 = RM. | last2 = Kok | first2 = K. | title = Fecal Calprotectin. | journal = Adv Clin Chem | volume = 87 | issue = | pages = 161-190 | month = | year = 2018 | doi = 10.1016/bs.acc.2018.07.005 | PMID = 30342711 }}</ref> | '''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal | last1 = Ayling | first1 = RM. | last2 = Kok | first2 = K. | title = Fecal Calprotectin. | journal = Adv Clin Chem | volume = 87 | issue = | pages = 161-190 | month = | year = 2018 | doi = 10.1016/bs.acc.2018.07.005 | PMID = 30342711 }}</ref> | ||
It is useful to differentiated IBD from irritable bowel syndrome,<ref>{{Cite journal | last1 = Nemakayala | first1 = DR. | last2 = Cash | first2 = BD. | title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? | journal = Curr Opin Gastroenterol | volume = 35 | issue = 1 | pages = 58-62 | month = Jan | year = 2019 | doi = 10.1097/MOG.0000000000000493 | PMID = 30407259 }} | It is useful to differentiated [[inflammatory bowel disease]] (IBD) from [[irritable bowel syndrome]],<ref name=pmid30407259>{{Cite journal | last1 = Nemakayala | first1 = DR. | last2 = Cash | first2 = BD. | title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? | journal = Curr Opin Gastroenterol | volume = 35 | issue = 1 | pages = 58-62 | month = Jan | year = 2019 | doi = 10.1097/MOG.0000000000000493 | PMID = 30407259 }}</ref> and may be used to assess IBD activity. | ||
</ref> and may be used to assess IBD activity. | |||
==See also== | ==See also== | ||
Revision as of 17:12, 16 February 2019
Fecal calprotectin is a 36kDa protein and an inflammatory marker.[1]
It is useful to differentiated inflammatory bowel disease (IBD) from irritable bowel syndrome,[2] and may be used to assess IBD activity.
See also
References
- ↑ Ayling, RM.; Kok, K. (2018). "Fecal Calprotectin.". Adv Clin Chem 87: 161-190. doi:10.1016/bs.acc.2018.07.005. PMID 30342711.
- ↑ Nemakayala, DR.; Cash, BD. (Jan 2019). "Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go?". Curr Opin Gastroenterol 35 (1): 58-62. doi:10.1097/MOG.0000000000000493. PMID 30407259.